Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: TSM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on TSM, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 39,222 TSM shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 39,222 shares
    Change vs previous 13F -2,722 shares

    0.34% of the 13F portfolio, value $18,731,251.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 41,944 shares
    Change vs previous 13F -4,418 shares

    0.27% of the 13F portfolio, value $14,174,975.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 46,362 shares
    Change vs previous 13F -23,561 shares

    0.3% of the 13F portfolio, value $14,090,005.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 69,923 shares
    Change vs previous 13F -7,713 shares

    0.44% of the 13F portfolio, value $19,530,268.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 77,636 shares
    Change vs previous 13F -55,373 shares

    0.55% of the 13F portfolio, value $17,585,119.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 133,009 shares
    Change vs previous 13F +29,305 shares

    0.69% of the 13F portfolio, value $22,081,266.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 103,704 shares
    Change vs previous 13F +26,686 shares

    0.71% of the 13F portfolio, value $20,482,157.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 77,018 shares
    Change vs previous 13F not available

    0.46% of the 13F portfolio, value $13,376,680.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).